United States · FDA National Drug Code directory
Indomethacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-029_ead13cff-b9d2-cdc1-e053-2a95a90adf09
- Product NDC
- 76420-029
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Indomethacin
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150724
- Source listing expiry
- 20261231
Source-listed ingredients
- INDOMETHACIN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-01) · 76420-029-01
- 2 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-02) · 76420-029-02
- 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-07) · 76420-029-07
- 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-14) · 76420-029-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →